HCTI

Healthcare Triangle, Inc. [HCTI] Stock Forecast

Q: What is Healthcare Triangle, Inc. stock symbol ?

Healthcare Triangle, Inc. is a US stock, located in Pleasanton of Ca and trading under the symbol HCTI

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

HCTI Stock Summary

HCTI has more than 11 years of cash runway (138 months)

Has a high level of debt. Debt-to-Equity ratio of 8.02 is considered high.

Earnings are expected to fall -100% next year

EPS has been decreasing for the past 3 years (Yearly statements)

EPS has been decreasing for the past 3 quarters (Quarter statements)

Does not have any significance market cap ($6.93M)

Top 10 Correlated ETFs

HCTI

Top 10 Correlated Stocks

HCTI

In the News

HCTI Financial details

Company Rating

Neutral

Market Cap

6.93M

Income

-12.34M

Revenue

33.2M

Book val./share

0.12

Cash/share

0.29

Dividend

Dividend %

Employees

Optionable

Shortable

Yes

Earnings

13 May 2024

P/E

-1.12

Forward P/E

PEG

-1.05

P/S

0.36

P/B

2.17

P/C

4.81

P/FCF

-14.23

Quick Ratio

0.62

Current Ratio

0.71

Debt / Equity

8.02

LT Debt / Equity

1.65

EPS (TTM)

-2.9

EPS next Y

EPS next Q

EPS this Y

11.45%

EPS next Y

EPS next 5Y

EPS last 5Y

NAN%

Revenue last 5Y

2.93%

Revenue Q/Q

-9.24%

EPS Q/Q

169.57%

SMA20

-21.47%

SMA50

-31.51%

SMA100

-61.93%

Inst Own

0.42%

Inst Trans

0.39%

ROA

-82%

ROE

-132%

ROC

-1.46%

Gross Margin

19%

Oper. Margin

-30%

Profit Margin

-32%

Payout

Shs Outstand

Shs Float

Target Price

52W Range

1.38-10.89

52W High

-86.06%

52W Low

+39.37%

RSI

34.1

Rel Volume

0.16

Avg Volume

126.43K

Volume

20.72K

Perf Week

-18.02%

Perf Month

-27.79%

Perf Quarter

-65.92%

Perf Half Y

-65.5%

Beta

0.994

Volatility

0.08%, 0.2%

Prev Close

5.58%

Price

1.3937

Change

0.27%

HCTI Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	8.17	8.91	11.99	12.49	7.85
Net income per share	0.33	0.67	-2.02	-2.62	-2.92
Operating cash flow per share	1.13	-0.21	-2.48	-0.71	-0.38
Free cash flow per share	0.09	-0.34	-3.54	-1.61	-0.38
Cash per share	0.28	0.4	0.6	0.36	0.29
Book value per share	0.56	1.23	5.48	3.37	0.13
Tangible book value per share	-0.27	0.49	1.49	0.14	-0.81
Share holders equity per share	0.56	1.23	5.48	3.37	0.13
Interest debt per share	0.01	0.24	1.37	0.71	1.25
Market cap	126.31M	126.31M	53.26M	6.61M	11.63M
Enterprise value	125.34M	125.66M	54.95M	7.68M	14.71M
P/E ratio	107.76	53.67	-8.95	-0.69	-0.94
Price to sales ratio	4.4	4.03	1.51	0.14	0.35
POCF ratio	31.83	-171.93	-7.3	-2.54	-7.21
PFCF ratio	396.13	-104.21	-5.11	-1.12	-7.16
P/B Ratio	63.96	29.18	3.3	0.53	21.62
PTB ratio	63.96	29.18	3.3	0.53	21.62
EV to sales	4.36	4.01	1.56	0.17	0.44
Enterprise value over EBITDA	51.26	63.47	-13.96	-1.09	-3.57
EV to operating cash flow	31.59	-171.05	-7.53	-2.96	-9.13
EV to free cash flow	393.07	-103.67	-5.27	-1.3	-9.05
Earnings yield	0.01	0.02	-0.11	-1.45	-1.06
Free cash flow yield	0	-0.01	-0.2	-0.9	-0.14
Debt to equity	0	0.17	0.21	0.19	8.02
Debt to assets	0	0.07	0.14	0.12	0.43
Net debt to EBITDA	-0.4	-0.33	-0.43	-0.15	-0.75
Current ratio	0.85	1.18	1.89	1.26	0.71
Interest coverage	31.75	14.96	-9.46	-49.13	-11.72
Income quality	3.39	-0.31	1.23	0.27	0.13
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0.06	0.08	0.13	0.12	0.16
Research and developement to revenue	0.04	0.06	0.15	0.13	0.02
Intangibles to total assets	0.35	0.24	0.48	0.57	0.4
Capex to operating cash flow	-0.92	0.65	0.43	1.28	0.01
Capex to revenue	-0.13	-0.02	-0.09	-0.07	0
Capex to depreciation	-4.7	-0.59	-2.2	-0.98	0
Stock based compensation to revenue	0	0	0	0.01	0
Graham number	2.05	4.3	15.79	14.09	2.89
ROIC	0.61	0.21	-0.27	-0.71	-2.34
Return on tangible assets	0.22	0.28	-0.46	-1.08	-2.03
Graham Net	-0.62	-0.16	0.19	-0.77	-1.38
Working capital	-906.83K	1.25M	5.55M	1.6M	-2.39M
Tangible asset value	-944.23K	1.71M	4.39M	529K	-3.43M
Net current asset value	-985.87K	1.25M	3.33M	-626K	-3.78M
Invested capital	0	0.17	0.21	0.19	8.02
Average receivables	0	5.28M	8.03M	7.63M	4.41M
Average payables	0	4.72M	3.11M	1.68M	1.72M
Average inventory	0	0	0	0.5	0.5
Days sales outstanding	52.97	74.5	100.1	44.48	35.57
Days payables outstanding	81.33	69.78	27.62	15.63	26.98
Days of inventory on hand	0	0	0	0	0
Receivables turnover	6.89	4.9	3.65	8.21	10.26
Payables turnover	4.49	5.23	13.22	23.36	13.53
Inventory turnover	0	0	0	34.59M	0
ROE	0.59	0.54	-0.37	-0.78	-22.93
Capex per share	-1.04	-0.14	-1.06	-0.9	0

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric	2022-12-31	2023-03-31	2023-06-30	2023-09-30	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	2.71	2.35	2.02	1.84	1.64
Net income per share	-1.17	-0.78	-0.42	-0.46	-1.24
Operating cash flow per share	-0.53	-0.38	-0.29	0.98	0.28
Free cash flow per share	-0.54	-0.38	-0.29	0.98	0.28
Cash per share	0.32	0.06	0.03	0.02	0.29
Book value per share	2.97	2.22	1.9	1.45	0.12
Tangible book value per share	0.13	-0.41	-0.51	-0.8	-0.8
Share holders equity per share	2.97	2.22	1.9	1.45	0.12
Interest debt per share	0.6	0.72	0.88	0.92	1.07
Market cap	7.51M	16.83M	9.85M	16.11M	11.85M
Enterprise value	8.58M	19.51M	13.25M	19.51M	14.93M
P/E ratio	-0.39	-1.28	-1.38	-2.07	-0.56
Price to sales ratio	0.66	1.71	1.16	2.07	1.68
POCF ratio	-3.37	-10.48	-8.07	3.9	9.76
PFCF ratio	-3.35	-10.47	-8.07	3.91	9.81
P/B Ratio	0.61	1.81	1.22	2.63	22.02
PTB ratio	0.61	1.81	1.22	2.63	22.02
EV to sales	0.76	1.98	1.55	2.51	2.12
Enterprise value over EBITDA	-2.23	-8.35	-16.71	-24.03	-84.84
EV to operating cash flow	-3.85	-12.15	-10.85	4.73	12.3
EV to free cash flow	-3.83	-12.14	-10.85	4.73	12.36
Earnings yield	-0.65	-0.19	-0.18	-0.12	-0.45
Free cash flow yield	-0.3	-0.1	-0.12	0.26	0.1
Debt to equity	0.19	0.32	0.44	0.57	8.02
Debt to assets	0.12	0.16	0.22	0.24	0.43
Net debt to EBITDA	-0.28	-1.15	-4.29	-4.19	-17.52
Current ratio	1.26	0.88	0.94	0.71	0.71
Interest coverage	-57.37	-51.76	-8.58	-3.67	-16.46
Income quality	0.46	0.49	0.68	-2.13	-0.23
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0.11	0.17	0.19	0.18	0.12
Research and developement to revenue	0.25	0.05	0.01	0.01	0.01
Intangibles to total assets	0.57	0.58	0.64	0.66	0.4
Capex to operating cash flow	0.01	0	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	-0.02	0	0	-0.01	0
Stock based compensation to revenue	0.02	0.01	0	0	-0.03
Graham number	8.83	6.26	4.25	3.87	1.86
ROIC	-0.32	-0.26	-0.14	-0.16	-1.04
Return on tangible assets	-0.55	-0.42	-0.3	-0.39	-0.88
Graham Net	-0.68	-1.23	-1.07	-1.21	-1.36
Working capital	1.6M	-890K	-366K	-1.96M	-2.39M
Tangible asset value	529K	-1.7M	-2.16M	-3.38M	-3.43M
Net current asset value	-626K	-3.12M	-2.59M	-3.45M	-3.78M
Invested capital	0.19	0.32	0.44	0.57	8.02
Average receivables	6.15M	5.55M	4.99M	4.34M	3.72M
Average payables	1.47M	1.39M	1.12M	1.04M	1.56M
Average inventory	0.5	0.5	0	0.5	0.5
Days sales outstanding	44.57	50.42	47.25	48.55	41.25
Days payables outstanding	14.06	14.27	12.67	17.21	31.78
Days of inventory on hand	0	0	0	0	0
Receivables turnover	2.02	1.78	1.9	1.85	2.18
Payables turnover	6.4	6.31	7.1	5.23	2.83
Inventory turnover	9.48M	0	0	6.07M	0
ROE	-0.39	-0.35	-0.22	-0.32	-9.91
Capex per share	0	0	0	0	0

HCTI Frequently Asked Questions

What is Healthcare Triangle, Inc. stock symbol ?

Healthcare Triangle, Inc. is a US stock , located in Pleasanton of Ca and trading under the symbol HCTI

What is Healthcare Triangle, Inc. stock quote today ?

Healthcare Triangle, Inc. stock price is $1.3937 today.

Is Healthcare Triangle, Inc. stock public?

Yes, Healthcare Triangle, Inc. is a publicly traded company.

Something similar

Top by Market Cap

Company Profile

Volume Average 126.43K
Market Capitalization 6.93M
Employee 31
CEO Mr. Anand Kumar
Headquarters Pleasanton,CA,US
IPO Date 2021-10-13
Website https://www.healthcaretriangle.com

Healthcare Triangle, Inc., a healthcare information technology company, focuses on developing solutions in the sectors of cloud services, data science, and professional and managed services. It provides a suite of software, solutions, platforms, and services that enables healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to evidence, and enhance the digital transformation. The company's software platforms include CloudEz, an enterprise multi-cloud transformation and management platform that enables customers to manage their cloud infrastructure across private, hybrid, and public cloud infrastructures; and DataEz, a cloud-based data analytics and data science platform for the data analytics and data science requirements of life sciences/pharmaceutical and healthcare provider organizations. It also provides Readabl.AI, a Software-as-a-Service solution that uses public cloud artificial intelligence and machine learning to recognize and extract healthcare information from documents, faxes, and narrative reports. In addition, it offers cloud IT services; and healthcare IT services, such as electronic health records and software implementation, optimization, and extension to community partners, as well as application managed services, and backup and disaster recovery on public cloud. The company primarily serves healthcare delivery organizations, healthcare insurance companies, pharmaceutical and life sciences, biotech companies, and medical device manufacturers. Healthcare Triangle, Inc. was incorporated in 2019 and is based in Pleasanton, California. Healthcare Triangle, Inc. operates as a subsidiary of SecureKloud Technologies, Inc.